Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garnero

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Hematological Oncology|August 1, 2008
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myelomaT E Sondergaard, P T Pedersen, T L Andersen, et al.
Annales De Biologie Clinique|December 1, 2000
[Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling]P Garnero, F Bianchi, M C Carlier, et al.
Annals of the Rheumatic Diseases|August 30, 2005
Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysisR B M Landewé, P Geusens, D M F M van der Heijde, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2006
Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosisD C Bauer, P Garnero, J P Bilezikian, et al.
Osteoarthritis and Cartilage|October 21, 2006
Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP studyI Meulenbelt, M Kloppenburg, H M Kroon, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 29, 2000
Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study GroupP J Meunier, E Vignot, P Garnero, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1996
Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective StudyP Garnero, E Hausherr, M C Chapuy, et al.
The Journal of Biological Chemistry|November 21, 1998
The collagenolytic activity of cathepsin K is unique among mammalian proteinasesP Garnero, O Borel, I Byrjalsen, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritisF Chopin, P Garnero, A le Henanff, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 7, 2002
In vivo assessment of architecture and micro-finite element analysis derived indices of mechanical properties of trabecular bone in the radiusD C Newitt, S Majumdar, B van Rietbergen, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Hematological Oncology|August 1, 2008
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myelomaT E Sondergaard, P T Pedersen, T L Andersen, et al.
Annales De Biologie Clinique|December 1, 2000
[Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling]P Garnero, F Bianchi, M C Carlier, et al.
Annals of the Rheumatic Diseases|August 30, 2005
Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysisR B M Landewé, P Geusens, D M F M van der Heijde, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2006
Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosisD C Bauer, P Garnero, J P Bilezikian, et al.
Osteoarthritis and Cartilage|October 21, 2006
Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP studyI Meulenbelt, M Kloppenburg, H M Kroon, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 29, 2000
Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study GroupP J Meunier, E Vignot, P Garnero, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1996
Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective StudyP Garnero, E Hausherr, M C Chapuy, et al.
The Journal of Biological Chemistry|November 21, 1998
The collagenolytic activity of cathepsin K is unique among mammalian proteinasesP Garnero, O Borel, I Byrjalsen, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritisF Chopin, P Garnero, A le Henanff, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 7, 2002
In vivo assessment of architecture and micro-finite element analysis derived indices of mechanical properties of trabecular bone in the radiusD C Newitt, S Majumdar, B van Rietbergen, et al.
Pageof 15